Status:
UNKNOWN
Assessing the Reliability of Non-invasive Blood Glucose Monitoring Device
Lead Sponsor:
GlucoVista
Conditions:
Diabetes Mellitus
Eligibility:
All Genders
18-85 years
Brief Summary
Adequate glycemic control in patients with Diabetes Mellitus (DM) is a desired therapeutic goal that is difficult to achieve with current blood glucose monitoring technology. Home blood glucose monito...
Eligibility Criteria
Inclusion
- Diabetes Mellitus type one or type two.
- Patients that are using Insulin.
Exclusion
- Vascular diseases
- Pregnant and lactating women.
- Exclusive use of long term Insulin.
Key Trial Info
Start Date :
November 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2021
Estimated Enrollment :
137 Patients enrolled
Trial Details
Trial ID
NCT01511861
Start Date
November 1 2010
End Date
December 1 2021
Last Update
February 19 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Edith Wolfson Medical Center
Holon, Israel